Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Diffusion Basis Spectrum Imaging of the Prostate

NCT: NCT04420702 · RECRUITING

NCT IDNCT04420702
StatusRECRUITING
Start Date2020-02-27
Completion2027-05-31
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑